Showing results (11-20 of 23) with videos related to
Sort By:
Pageof 3
Neuropeptides|March 9, 2005
Acute, subacute and chronic effects of central neuropeptide Y on energy balance in ratsM Székely, E Pétervári, E Pákai, et al.Journal of Pediatric Gastroenterology and Nutrition|August 1, 2015
Adherence to Oral Maintenance Treatment in Adolescents With Inflammatory Bowel DiseaseLieke M Spekhorst, Thalia Z Hummel, Marc A Benninga, et al.Journal of Pediatric Gastroenterology and Nutrition|May 16, 2012
Additional value of upper GI tract endoscopy in the diagnostic assessment of childhood IBDThalia Z Hummel, Fiebo J W ten Kate, Johannes B Reitsma, et al.Journal of Pediatric Gastroenterology and Nutrition|July 25, 2013
Psychosocial developmental trajectory of adolescents with inflammatory bowel diseaseThalia Z Hummel, Eline Tak, Heleen Maurice-Stam, et al.Journal of Pediatric Gastroenterology and Nutrition|October 30, 2013
Exogenous pigment in Peyer patches of children suspected of having IBDThalia Z Hummel, Angelika Kindermann, Pieter C F Stokkers, et al.Journal of Pediatric Gastroenterology and Nutrition|May 5, 2017
Application of Population Pharmacokinetic Modeling for Individualized Infliximab Dosing Strategies in Crohn DiseaseAdam Frymoyer, Daniël R Hoekman, Travis L Piester, et al.Scandinavian Journal of Gastroenterology|April 14, 2015
The association of infliximab trough levels with disease activity in pediatric inflammatory bowel diseaseDaniël R Hoekman, Johannan F Brandse, Tim G de Meij, et al.Neuropediatrics|March 8, 2000
Unilateral thalamic lesions in premature infants: risk factors and short-term prognosisG van Wezel-Meijler, T Z Hummel, J Oosting, et al.Alimentary Pharmacology & Therapeutics|April 26, 2016
The prevalence of irritable bowel syndrome-type symptoms in paediatric inflammatory bowel disease, and the relationship with biochemical markers of disease activityK Diederen, D R Hoekman, T Z Hummel, et al.Alimentary Pharmacology & Therapeutics|February 1, 2017
Raised faecal calprotectin is associated with subsequent symptomatic relapse, in children and adolescents with inflammatory bowel disease in clinical remissionK Diederen, D R Hoekman, A Leek, et al.Pageof 3